TRPC6: Difference between revisions

From Food & Medicine Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
'''TRPC6''' is a member of the canonical transient receptor potential (TRPC) subfamily of proteins that are expressed in various tissues and play a role in [[receptor-operated calcium channels|receptor-operated Ca2+ channels]]. TRPC6 is encoded by the [[TRPC6 gene]] in humans.
== TRPC6 ==


== Function ==
[[File:TRPCandBK.jpg|thumb|right|Diagram illustrating TRPC6 channel structure and function.]]
TRPC6 is a non-selective cation channel that is activated in response to signals from [[G-protein coupled receptors]]. It is involved in various physiological processes, including the regulation of systemic blood pressure, pulmonary artery smooth muscle cell proliferation, and [[glomerular filtration rate]].


== Clinical significance ==
'''TRPC6''' is a member of the [[transient receptor potential channel]] (TRPC) family, which are a group of [[ion channels]] located in the [[cell membrane]]. These channels are involved in various physiological processes, including the regulation of [[calcium]] influx into cells. TRPC6 is particularly important in the [[kidney]], [[lung]], and [[vascular system]].
Mutations in the TRPC6 gene have been associated with several diseases, including [[focal segmental glomerulosclerosis]] (FSGS) and [[pulmonary arterial hypertension]] (PAH). In FSGS, mutations in TRPC6 lead to an increase in calcium influx, which results in podocyte injury and proteinuria. In PAH, TRPC6 overexpression contributes to the proliferation of pulmonary artery smooth muscle cells, leading to vascular remodeling and increased pulmonary vascular resistance.


== Research ==
=== Structure ===
Research on TRPC6 has focused on its role in disease pathogenesis and potential as a therapeutic target. Studies have shown that inhibiting TRPC6 activity can reduce proteinuria in animal models of FSGS, suggesting that TRPC6 inhibitors could be a potential treatment for this disease. Similarly, TRPC6 inhibitors have been shown to reduce pulmonary artery smooth muscle cell proliferation in PAH, suggesting a potential therapeutic role in this condition as well.
TRPC6 channels are composed of six transmembrane domains with a pore region between the fifth and sixth domains. The channel is activated by [[diacylglycerol]] (DAG) in a [[phospholipase C]] (PLC)-dependent manner, but it is independent of [[inositol trisphosphate]] (IP3). This distinguishes TRPC6 from other TRPC family members.


== See also ==
=== Function ===
TRPC6 plays a crucial role in the regulation of [[glomerular filtration rate]] in the kidney by modulating the contraction of [[podocytes]]. In the [[vascular system]], TRPC6 is involved in the regulation of [[smooth muscle cell]] contraction and [[blood pressure]].
 
=== Clinical Significance ===
Mutations in the TRPC6 gene have been associated with [[focal segmental glomerulosclerosis]] (FSGS), a disease that affects the kidney's filtering units. These mutations can lead to altered channel function, resulting in proteinuria and progressive kidney damage.
 
== Related pages ==
* [[Ion channel]]
* [[Calcium signaling]]
* [[Transient receptor potential channel]]
* [[Transient receptor potential channel]]
* [[Focal segmental glomerulosclerosis]]
* [[Focal segmental glomerulosclerosis]]
* [[Pulmonary arterial hypertension]]
== References ==
<references />


[[Category:Ion channels]]
[[Category:Ion channels]]
[[Category:Proteins]]
[[Category:Membrane proteins]]
[[Category:Genes]]
[[Category:Human proteins]]
[[Category:Medical genetics]]
[[Category:Cardiovascular diseases]]
[[Category:Renal diseases]]
 
{{stub}}

Latest revision as of 04:02, 13 February 2025

TRPC6[edit]

File:TRPCandBK.jpg
Diagram illustrating TRPC6 channel structure and function.

TRPC6 is a member of the transient receptor potential channel (TRPC) family, which are a group of ion channels located in the cell membrane. These channels are involved in various physiological processes, including the regulation of calcium influx into cells. TRPC6 is particularly important in the kidney, lung, and vascular system.

Structure[edit]

TRPC6 channels are composed of six transmembrane domains with a pore region between the fifth and sixth domains. The channel is activated by diacylglycerol (DAG) in a phospholipase C (PLC)-dependent manner, but it is independent of inositol trisphosphate (IP3). This distinguishes TRPC6 from other TRPC family members.

Function[edit]

TRPC6 plays a crucial role in the regulation of glomerular filtration rate in the kidney by modulating the contraction of podocytes. In the vascular system, TRPC6 is involved in the regulation of smooth muscle cell contraction and blood pressure.

Clinical Significance[edit]

Mutations in the TRPC6 gene have been associated with focal segmental glomerulosclerosis (FSGS), a disease that affects the kidney's filtering units. These mutations can lead to altered channel function, resulting in proteinuria and progressive kidney damage.

Related pages[edit]